Sponsor
Warren Davidson
Representative · R-OH
Representative · R-OH
The bill centralizes federal health and biomedical oversight into one House committee to improve focus and speed in health policy and emergency response, while trading off higher administrative costs, short-term transition disruption, and the risk of concentrating authority that could reduce cross-committee checks.
Patients, hospitals, biomedical researchers, and public-health stakeholders will see more focused legislative attention because a single House Committee on Health centralizes responsibility for biomedical research, FDA oversight, CDC, and public-health policy, likely improving policy expertise and coordination.
Hospitals, patients, and medical innovators could benefit from faster policymaking and more coherent oversight in health emergencies and medical innovation because oversight of public health and biomedical research is consolidated under one committee.
Taxpayers and legislators face clearer committee jurisdictions because health insurance programs are removed from Education and the Workforce and related jurisdictional overlaps are reduced, which should lower intercommittee conflict and streamline bill drafting.
Patients, hospitals, and public-health decisionmaking could face reduced cross-committee perspectives and less dispersed oversight because FDA, CDC, and biomedical research oversight is concentrated in a single committee, risking narrower policy advice and potential industry or interest capture.
Hospitals, patients, and stakeholders may experience temporary slowdowns in legislation and oversight as jurisdictional responsibilities are reassigned and staff expertise is realigned during the transition to the new committee structure.
Taxpayers will face increased federal spending because creating and staffing a new standing committee increases congressional administrative and staff costs.
Based on analysis of 2 sections of legislative text.
Creates a new House Committee on Health and reallocates oversight jurisdiction for biomedical research, public health, and non‑veterans health care among House committees.
Creates a new standing House Committee on Health by amending House Rule X and reallocates jurisdiction over biomedical research, public health, and health care funded by general revenues (except veterans’ medical care). It reshuffles clause designations in the Rules, narrows the Committee on Education and the Workforce’s jurisdiction by excepting health insurance programs, and removes certain subparagraphs from the Committee on Energy and Commerce’s jurisdiction language to reflect the new committee allocation. The change is a procedural reorganization of committee responsibilities: it does not create new federal programs or appropriate funds but shifts oversight and legislative jurisdiction over many health-related topics from existing committees to a newly created Committee on Health.
Official title: Amending the Rules of the House of Representatives to establish a Committee on Health as a standing committee of the House.
Introduced January 3, 2025 by Warren Davidson · Last progress January 3, 2025